close

Mergers and Acquisitions

1 30 31 32
Number of results: 631
Date Acquired company Acquiring company Amount Related
2011-02-22 iNovia (Sweden) Kancera (Sweden) undisclosed

services

2011-02-21 Prostrakan (UK) Kyowa Hakko Kirin (Japan) £ 292 million(€ 345,3 million) specialty pharma
2011-02-16 Genzyme (USA) Sanofi Aventis (France) $ 20,1 billion

Rare diseases
Endocrinology
Hematology
Oncology
Biosurgery

2011-02-09 Kinaxo (Germany) Evotec (Germany) €12 million

Drug discovery
Drug development
Oncology

2011-01-31 UK manufacturing facility from RecipharmCobra Biologics Oxford BioMedica (UK) £1.9 million (€2.2 million)

Manufacturing
Production
Gene therapy

2011-01-25 Santhera Pharmaceuticals (Switzerland) Newron Pharmaceuticals (Italy)
2011-01-24 Genoptix (USA) Novartis (Switzerland) $470 million (€344 million)

Personalized medicine

2011-01-10 Synosia Therapeutics (Switzerland) Biotie Therapies (Finland) € 93.6 million
0000-00-00
0000-00-00 Vtesse (USA - MD) Sucampo Pharmaceuticals (USA - MA) $200 million Rare diseases - Genetic diseases
0000-00-00 Universal Cells (USA - WA) Astellas Pharma (Japan) up to $102.5 million Technology - Services - Regenerative Medicine